id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2017-N-5101-0032,FDA,FDA-2017-N-5101,Correction from Consumer Healthcare Products Association (CHPA),Other,Correction(s),2018-02-16T05:00:00Z,2018,2,2018-02-16T05:00:00Z,,2018-02-16T15:17:45Z,,0,0,0900006482f38f2d
FDA-2017-N-5101-0007,FDA,FDA-2017-N-5101,"Review of Existing Regulatory and Information Collection Requirements;
Extension of Comment Period",Proposed Rule,Extension of Comment Period,2017-12-06T05:00:00Z,2017,12,2017-12-06T05:00:00Z,2018-02-06T04:59:59Z,2018-02-06T14:03:57Z,2017-26199,0,0,0900006482ce9c5b
FDA-2017-N-5101-0001,FDA,FDA-2017-N-5101,Review of Existing Center for Drug Evaluation and Research Regulatory and Information Collection Requirements,Proposed Rule,Request for Comment,2017-09-08T04:00:00Z,2017,9,2017-09-08T04:00:00Z,2017-12-08T04:59:59Z,2017-12-08T02:01:23Z,2017-19033,0,0,0900006482b17975